ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ramm Pharma Corp

Ramm Pharma Corp (RAMM)

0.02
0.005
( 33.33% )
Updated: 02:48:39

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.02
Bid
0.015
Offer
0.025
Volume
276,000
0.02 Day's Range 0.02
0.005 52 Week Range 0.065
Previous Close
0.015
Open
0.02
Last Trade
276000
@
0.02
Last Trade Time
02:48:39
Average Volume (3m)
53,383
Financial Volume
-
VWAP
-

RAMM Latest News

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

TORONTO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma announces its quarter financial results for Q2 2020

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

TORONTO, April 15, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course...

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update

TORONTO, March 23, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals

TORONTO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil

TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00533.33333333330.0150.020.015140000.015CS
40.011000.010.020.01320090.01472434CS
120.011000.010.020.005533830.01430701CS
26000.020.020.005304960.01531909CS
52-0.025-55.55555555560.0450.0650.005438750.02407633CS
156-0.29-93.54838709680.310.350.005741500.12447567CS
260-0.82-97.6190476190.841.190.005826440.35799832CS

RAMM - Frequently Asked Questions (FAQ)

What is the current Ramm Pharma share price?
The current share price of Ramm Pharma is $ 0.02
What is the 1 year trading range for Ramm Pharma share price?
Ramm Pharma has traded in the range of $ 0.005 to $ 0.065 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VLTAVolta Metals Ltd
$ 0.045
(125.00%)
1.41M
FNQFineqia International Inc
$ 0.01
(100.00%)
141.4k
BLRBlackhawk Growth Corp
$ 0.01
(100.00%)
60k
PUMPStock Trend Capital Inc
$ 0.01
(100.00%)
900k
CATCAT Strategic Metals Corporation
$ 0.01
(100.00%)
17k
HROHero Innovation Group Inc
$ 0.075
(-60.53%)
11.25k
SQXSquatex Energy and Ressources Inc
$ 0.005
(-50.00%)
100.01k
OWLIOne World Lithium Inc
$ 0.015
(-25.00%)
303k
AETHAether Global Innovations Corp
$ 0.015
(-25.00%)
8k
CMTCullinan Metals Corp
$ 0.015
(-25.00%)
104k
LEXTLexston Mining Corporation
$ 0.015
(-14.29%)
1.52M
VLTAVolta Metals Ltd
$ 0.045
(125.00%)
1.41M
AUMCAuric Minerals Corp
$ 1.96
(29.80%)
1.07M
PKKPeak Fintech Group Inc
$ 0.05
(-9.09%)
1.05M
PUMPStock Trend Capital Inc
$ 0.01
(100.00%)
900k

Discussion

View Full Feed
getmoreshares getmoreshares 5 minutes ago
https://pbs.twimg.com/media/GhQ-XyIXcAAqFnJ?format=jpg&name=small
AZRH
tw0122 tw0122 5 minutes ago
Panty size done by AI $2.94 peak
$2.74
MYSZ
Maplelakester Maplelakester 6 minutes ago
I wouldn't be surprised if trades at this level are being "engineered" to shake the tree a little. In the past I've put in market orders trying to buy on dips like this and not been filled. Not sure how that works, but it definitely happens.
MGON
Azart Azart 6 minutes ago
The only thing Scamus Looking knows well is bringing stock price down to .0001 and calling for a reverse split allowing him to do it all over again
RNVA
edbk46 edbk46 6 minutes ago
Goldman

interesting

slowly slowly the wheel turns

WMI FNMA LEH

https://www.wsj.com/finance/banking/goldman-sees-financing-as-the-future-it-is-rearranging-itself-to-reflect-that-72a22cd7?mod=hp_lead_pos1
Goldman Sachs GS 0.53%increase
LEHNQ
pinhigh pinhigh 6 minutes ago
Yup toohot...From what I've seen....very few Biel longs have been willing to abandon their investment. Very comforting!
BIEL
trucker20 trucker20 6 minutes ago
Doesn't anyone else think it would be a pretty good idea to roll out the app, before next week's Tik Tok ban comes into effect? Just saying.
BBUZ
linkvest linkvest 6 minutes ago
They are stacking the 13s going into the lunch hour to try and get those 12s. Typical lunch time lulls manipulations happening... Slap that wall and watch how fast if runs away....
RDAR
scotty3371 scotty3371 6 minutes ago
Like I said Linda lost her audience about five years ago. It's just a dilution machine with little upside. Almost 20 years of nothing burgers.

P to the M...LOL
NWBO
BDR10 BDR10 6 minutes ago
All this good news along with the short squeeze is pulling this stock price down.... approval partnership or a buyout is all that matters with this stock everything else is nothing more than word salad..
AVXL
RickNagra RickNagra 7 minutes ago
I believe these gains are due to Whalen.  He changed his tune this morning.  No doubt he is well connected with whales.
FNMA
edbk46 edbk46 7 minutes ago
Interesting

Fnma is running today with heavy bids
6.5+

Coop 4+


imho

FNMA first

then us

follow by Leh
💚
Quote
Quick Edit
More...
LEHNQ
tw0122 tw0122 8 minutes ago
Again watxh out halt this low floater power
&9.34 + 57% 
XXII
williamssc williamssc 8 minutes ago
It is huge so maybe the morning of Thursday's conference.
AVXL
krab krab 8 minutes ago
Enjoy, get both !!
FNMA
Thunderstruck Thunderstruck 8 minutes ago
Yup!!! Exactly....buying some here! Volume is terrific!
RDAR
zxjoshuaxz zxjoshuaxz 8 minutes ago
You're insane if you think Trump is going to care about what these idiots are saying. Why have they been silent for the past 4 years? They are only speaking now because they're scared and know that the inevitable is coming. Listen to Ackman and Paulson. We also have that letter and the first Trump a
FNMA
jcromeenes jcromeenes 9 minutes ago
Rick, go beat up Sherwin. I don't like the give back.
FNMA
BlazingStocks BlazingStocks 9 minutes ago
$ILLR - A Game-Changing Strategic Vision
Kicking off the session, Wing Fai Ng, the Company’s CEO, and Mark Carbeck, Triller Corp.’s CFO, unveiled the rationale behind the recent merger, revealing their bold vision to create an “everything ecosystem” that seamlessly integrates social media, so
ILLR
La Flaca La Flaca 9 minutes ago
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency.

The seven-year FDA veteran communicated the decision in an internal communication viewed by Fierce Pharma. Her last day will be Jan. 18.
AVXL
linkvest linkvest 9 minutes ago
MMs are sliding the 14s down on to the 13s making the 14s even more thinner.
RDAR
rx7171 rx7171 9 minutes ago
I note his reference to “functional benefits”
The initial 48 week trial missed statistical significance for the ADL co primary end point.
This is the basis for skepticism by some although countered with the argument that for a short trial of early AD this is very hard to accurately obs
AVXL
jwood9207 jwood9207 10 minutes ago
CBO has zero authority and even less influence.
FNMA
prototype_101 prototype_101 10 minutes ago
From the link,

Key Players:

Profiles of some of the major players in the global Silicon Photonics market, which include:

AIO Core Co. Ltd., FormFactor, Polariton Technologies AG, SCINTIL Photonics, STMicroelectronics, FUJITSU, EFFECT PHOTONICS, RONOVUS, N
LWLG

Your Recent History

Delayed Upgrade Clock